Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Skin Cancer01:30

Skin Cancer

5.6K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.6K
Renewal of Skin Epidermal Stem Cells01:12

Renewal of Skin Epidermal Stem Cells

2.9K
The skin is divided into epidermis, dermis, and hypodermis, the skin's outermost, middle, and inner layers. The human epidermal layer regularly undergoes renewal, where old, dead cells are replaced by new cells. Epidermal stem cells or EpiSCs divide and differentiate to restore the lost cells. For the renewal process, some EpiSCs continuously self-renew. In contrast, few others differentiate into transit-amplifying cells, which later form prickle or spinous cells, followed by granular...
2.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-life effectiveness and safety of bimekizumab in patients with moderate plaque psoriasis: a 54-week multicentre study in the Lazio region.

Drugs in context·2026
Same author

The role of dupilumab in skin microbiome shifts in the Netherton genodermatosis: a case report and review of literature.

Frontiers in medicine·2026
Same author

A methodology for constructing and assessing a combined experimental and computational validation domain for patient-specific mandibular reconstruction.

Journal of the mechanical behavior of biomedical materials·2026
Same author

Surgical Outcomes of Nonmelanoma Skin Cancer Managed with Systematic Preoperative Reflectance Confocal Microscopy-Guided Margin Assessment: A Retrospective Cohort Study Comparing Wide Local Excision and Mohs Micrographic Surgery.

Diagnostics (Basel, Switzerland)·2026
Same author

Towards Accurate Breslow Measurements: Mitigating Issues in Histopathological Imaging.

Entropy (Basel, Switzerland)·2026
Same author

Immunohistochemical characterization of somatically derived "yolk sac tumors": analysis of a multi-institutional case series.

Virchows Archiv : an international journal of pathology·2026

Related Experiment Video

Updated: Dec 12, 2025

Combining Reflectance Confocal Microscopy with Optical Coherence Tomography for Noninvasive Diagnosis of Skin Cancers via Image Acquisition
09:37

Combining Reflectance Confocal Microscopy with Optical Coherence Tomography for Noninvasive Diagnosis of Skin Cancers via Image Acquisition

Published on: August 18, 2022

2.7K

Basal Cell Carcinoma: A Comprehensive Review.

Emi Dika1,2, Federica Scarfì1,2, Manuela Ferracin3

  • 1Division of Dermatology, Azienda Ospedaliero-Universitaria di Bologna, via Massarenti 9, 40138 Bologna, Italia.

International Journal of Molecular Sciences
|August 8, 2020
PubMed
Summary

Basal cell carcinoma (BCC) research is advancing, focusing on genetic factors and treatment resistance. MicroRNAs (miRNAs) are emerging as key players in understanding BCC biology and therapy resistance.

Keywords:
basal cell carcinomagenetichedgehog pathway inhibitorsmicroRNAsonidegibtreatmentvismodegib

More Related Videos

Cell Population Analyses During Skin Carcinogenesis
06:53

Cell Population Analyses During Skin Carcinogenesis

Published on: August 21, 2013

12.8K
Establishment of a Clinic-based Biorepository
07:50

Establishment of a Clinic-based Biorepository

Published on: May 29, 2017

6.8K

Related Experiment Videos

Last Updated: Dec 12, 2025

Combining Reflectance Confocal Microscopy with Optical Coherence Tomography for Noninvasive Diagnosis of Skin Cancers via Image Acquisition
09:37

Combining Reflectance Confocal Microscopy with Optical Coherence Tomography for Noninvasive Diagnosis of Skin Cancers via Image Acquisition

Published on: August 18, 2022

2.7K
Cell Population Analyses During Skin Carcinogenesis
06:53

Cell Population Analyses During Skin Carcinogenesis

Published on: August 21, 2013

12.8K
Establishment of a Clinic-based Biorepository
07:50

Establishment of a Clinic-based Biorepository

Published on: May 29, 2017

6.8K

Area of Science:

  • Dermatology
  • Oncology
  • Molecular Biology

Background:

  • Basal cell carcinoma (BCC) is the most common human cancer globally.
  • BCC arises from complex interactions of environmental, genetic, and phenotypic factors.
  • Understanding BCC biology and treatment resistance remains a critical research gap.

Purpose of the Study:

  • To review BCC's histological and molecular characteristics.
  • To focus on the molecular underpinnings of systemic BCC therapies.
  • To explore microRNA (miRNA) dysregulation in BCC and treatment resistance.

Main Methods:

  • Literature review of papers published in the last ten years.
  • Inclusion of studies on BCC genetic and phenotypic alterations.
  • Focus on mechanisms of resistance to hedgehog pathway inhibitors (vismodegib, sonidegib).

Main Results:

  • BCC development involves intricate genetic and environmental interactions.
  • Hedgehog pathway inhibitors are key systemic therapies for BCC.
  • MicroRNA (miRNA) dysregulation is increasingly implicated in BCC resistance.

Conclusions:

  • A deeper understanding of BCC molecular features is crucial.
  • Investigating miRNA involvement in treatment resistance is a promising new avenue.
  • Further research into BCC biology and resistance mechanisms is warranted for improved therapies.